These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 31838587
41. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity. Han QX, Wang Y, Zhu HY, Zhang D, Gao J, Liu ZS, Cai GY, Chen XM. Chin Med J (Engl); 2019 Mar 20; 132(6):647-652. PubMed ID: 30855344 [Abstract] [Full Text] [Related]
42. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study. Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H. BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758 [Abstract] [Full Text] [Related]
43. Markers for the progression of IgA nephropathy. Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V. J Nephrol; 2016 Aug 30; 29(4):535-41. PubMed ID: 27142988 [Abstract] [Full Text] [Related]
44. Metabolomics study reveals blood biomarkers for early diagnosis of chronic kidney disease and IgA nephropathy: A retrospective cross-sectional study. Fu X, Luo ZX, Yin HH, Liu YN, Du XG, Cheng W, Liu JY. Clin Chim Acta; 2024 Mar 01; 555():117815. PubMed ID: 38309556 [Abstract] [Full Text] [Related]
45. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy. Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH. Nephrol Dial Transplant; 2012 May 01; 27(5):1916-23. PubMed ID: 21940483 [Abstract] [Full Text] [Related]
46. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy. Chen X, Chen Y, Shi K, Lv Y, Tong H, Zhao G, Chen C, Chen B, Li D, Lu Z. Sci Rep; 2017 Sep 13; 7(1):11468. PubMed ID: 28904360 [Abstract] [Full Text] [Related]
47. Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study. Satoskar AA, Shapiro JP, Jones M, Bott C, Parikh SV, Brodsky SV, Yu L, Nagaraja HN, Wilkey DW, Merchant ML, Klein JB, Nadasdy T, Rovin BH. Sci Rep; 2020 Oct 14; 10(1):17179. PubMed ID: 33057112 [Abstract] [Full Text] [Related]
48. Clinical and histological features and therapeutic strategies for IgA nephropathy. Moriyama T. Clin Exp Nephrol; 2019 Sep 14; 23(9):1089-1099. PubMed ID: 30968243 [Abstract] [Full Text] [Related]
49. Mapping novel immunogenic epitopes in IgA nephropathy. Woo SH, Sigdel TK, Dinh VT, Vu MT, Sarwal MM, Lafayette RA. Clin J Am Soc Nephrol; 2015 Mar 06; 10(3):372-81. PubMed ID: 25542908 [Abstract] [Full Text] [Related]
50. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy. Genovese F, Boor P, Papasotiriou M, Leeming DJ, Karsdal MA, Floege J. Nephrol Dial Transplant; 2016 Mar 06; 31(3):472-9. PubMed ID: 26311218 [Abstract] [Full Text] [Related]
51. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K. Kidney Int; 2001 Mar 06; 59(3):1077-85. PubMed ID: 11231363 [Abstract] [Full Text] [Related]
52. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H. Int Immunopharmacol; 2019 Jan 06; 66():13-18. PubMed ID: 30415190 [Abstract] [Full Text] [Related]
53. Pattern of renal beta 1(alpha 1-alpha 6) integrins distribution in IgA nephropathy and Henoch-Schoenlein nephritis. Wagrowska-Danilewicz M, Danilewicz M. Pol J Pathol; 2002 Jan 06; 53(2):51-7. PubMed ID: 12140867 [Abstract] [Full Text] [Related]
54. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals]. Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical AssociationDepartment of Pediatrics, the First Affiliated Hospital, SUN Yat-sen University, Guangzhou 510080, China., Jiang XY. Zhonghua Er Ke Za Zhi; 2007 Apr 06; 45(4):272-8. PubMed ID: 17706064 [Abstract] [Full Text] [Related]
55. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease. Rauta V, Finne P, Fagerudd J, Rosenlöf K, Törnroth T, Grönhagen-Riska C. Clin Nephrol; 2002 Aug 06; 58(2):85-94. PubMed ID: 12227693 [Abstract] [Full Text] [Related]
56. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy. Tariq A, Mansoor MA, Marti HP, Jonsson G, Slettan A, Weeraman P, Apeland T. Clin Biochem; 2018 Jun 06; 56():33-40. PubMed ID: 29655960 [Abstract] [Full Text] [Related]
57. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study. Calvo-Río V, Loricera J, Martín L, Ortiz-Sanjuán F, Alvarez L, González-Vela MC, González-Lamuño D, Mata C, Gortázar P, Rueda-Gotor J, Arias M, Peiró E, Martínez-Taboada VM, González-Gay MA, Blanco R. Clin Exp Rheumatol; 2013 Jun 06; 31(1 Suppl 75):S45-51. PubMed ID: 23663681 [Abstract] [Full Text] [Related]
58. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S. Nephrol Dial Transplant; 2008 Jun 06; 23(6):1931-9. PubMed ID: 18178603 [Abstract] [Full Text] [Related]
59. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F. Kidney Int; 2015 Oct 06; 88(4):815-22. PubMed ID: 26061544 [Abstract] [Full Text] [Related]
60. [Clinical and pathological features of IgA nephropathy in west Guangdong province]. Chen WL, Lin HP, Liu HF. Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 06; 30(5):1150-1. PubMed ID: 20501418 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]